Nu Skin (NUS) is on the Hedgeye Consumer Staples Best Ideas list as a SHORT.




Today, Barron’s ran an article on VitaMeal raising some of the concerns that we have, but the article lacks many of the details around VitaMeal and the implication for NUS.


It's important to remember that NUS is currently under investigation by the SEC.  Our call focuses on the process, ethics and execution of getting the needy children the food, which is questionable at best.  If the SEC were to expand the scope of its investigation into NUS's business practices it would be financially devastating to the company.    


Our call on Wednesday, November 11th, will cover the following topics that were not covered in the Barron's article

  1. Quarterly impact on NUS's sales and EPS since Q1 2012
  2. How NUS's multiple charities work jointly to sell VitaMeal
  3. An example of how distributors may be deceiving consumers (see graphic below)
  4. Names of the people and organizations in Malawi that are tied to NUS
  5. Why VitaMeal could increase the scope of the SEC investigation into NUS
  6. The financial condition of NUS and why this scandal could cripple the company
  7. And more...




The Barrons article also referenced a call, General Counsel Noah Bryson, had with VitaMeal distributors in October.  We have a transcript of that call available if you would like to read it.  Its quite entertaining.


Call with questions or contact if you would like to listen to the call.



Howard Penney

Managing Director


Shayne Laidlaw


Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more

A 'Toxic Cocktail' Brewing for A Best Idea Short

The first quarter earnings pre-announcement today is not the end of the story for Mednax (MD). Rising labor costs and slowing volume is a toxic cocktail...

read more

Energy Stocks: Time to Buy? Here's What You Need to Know

If you're heavily-invested in Energy stocks it's been a heck of a year. Energy is the worst-performing sector in the S&P 500 year-to-date and value investors are now hunting for bargains in the oil patch. Before you buy, here's what you need to know.

read more

McCullough: ‘My 1-Minute Summary of My Institutional Meetings in NYC Yesterday’

What are even some of the smartest investors in the world missing right now?

read more

Cartoon of the Day: Political Portfolio Positioning

Leave your politics out of your portfolio.

read more

Jim Rickards Answers the Hedgeye 21

Bestselling author Jim Rickards says if he could be any animal he’d be a T-Rex. He also loves bonds and hates equities. Check out all of his answers to the Hedgeye 21.

read more

Amazon's New 'Big Idea': Ignore It At Your Own Peril

"We all see another ‘big idea’ out of Amazon (or the press making one up) just about every day," writes Retail Sector Head Brian McGough. "But whatever you do, DON’T ignore this one!"

read more